Jennifer Fulk
CIK: 0001873522
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Sep 8, 2026KURA
Kura Oncology, Inc.
Award(A)DirectOption to purchase common stock
450K shares- - May 18, 2026SLNO
SOLENO THERAPEUTICS INC
Disposition(D)Direct39.2K shares- - Mar 2, 2026SLNO
SOLENO THERAPEUTICS INC
Award(A)Direct39.2K shares- - Mar 2, 2026SLNO
SOLENO THERAPEUTICS INC
Exercise(M)DirectEmployee stock option (right to buy)
67.7K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 8, 2026 |  KURA Kura Oncology, Inc. | Award(A) Option to purchase common stock | 450,000 | - | - | Direct |
| May 18, 2026 |  SLNO SOLENO THERAPEUTICS INC | Disposition(D) | 39,200 | - | $0 | Direct |
| Mar 2, 2026 | SLNO SOLENO THERAPEUTICS INC | Award(A) | 39,200 | - | $0 | Direct |
| Mar 2, 2026 | SLNO SOLENO THERAPEUTICS INC | Exercise(M) Employee stock option (right to buy) | 67,660 | - | - | Direct |
1-4 of 4 transactions
About Fulk Jennifer
Fulk Jennifer (SEC CIK 0001873522) files insider reports with the SEC as Chief Financial Officer of Kura Oncology, Inc. (KURA) and CHIEF FINANCIAL OFFICER of SOLENO THERAPEUTICS INC (SLNO).
Signal8 holds 5 ownership filings by Fulk Jennifer (2 Form 3, 3 Form 4), filed between Mar 4, 2026 and Sep 10, 2026. Those filings report 4 transactions, from Mar 2, 2026 to Sep 8, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Fulk Jennifer's filings is in SAN DIEGO, CA.
Recent filings by Fulk Jennifer
Other insiders filing for Kura Oncology, Inc. (KURA)
- Bair Teresa Brophy, Chief Legal Officer
- FORD KATHLEEN, Chief Operating Officer
- Leoni Mollie, Chief Medical Officer
- DOYLE THOMAS JAMES, SVP, Finance & Accounting
- Powl Brian T., Chief Commercial Officer
- Burrows Francis, Chief Scientific Officer